Member Info for year1970

Jonjo, as a very long term holder and my shares lost about 98% of its value I can tell you that we talked about this for years, the problem Val facing is because it spends so much money every year for at least the last 5 years and the reasons for this 1) they do multiple trials on their own also developing new compounds at the same time, they either know this would harm the sp but still go ahead or they didn't expect the whole thing was costing so much money. 2) the bod wages is not cheap, they all have good salary.

I don't invest in Sar but I think they were quite clever by doing trials with another company so they don't desperate needing money like Val as the result they are doing ok after years also I think Sclp is going the same route but I don't follow them that much.

As investors we need to be clear and accept that not every trial is a success and majority will fail or get to nowhere especially with cancer and Val is no exception and if failed it won't be fault because the trials is not done by them, it is by erteenal experts, but we don't know yet, by the look of val401 it does not look impressive. But for me it is not worth to sell but for anyone new, in aim market you need to trade, Val could be up 50% tomorrow but also the other way round, always set a target and not be greedy. There will be ups and downs...

coffeecups, I rarely post on here or any other share at all and only started to post since 2012 (I think), I don't follow many companies, probably around 20-40 so I don't know the companies you listed and not sure of your question. But one thing everyone must agree with me is that not many people making profit in AIM, majority are in red including myself and only a handful actually making anything but we are human and keep hoping...

Teacup64, if everyone followed your suggestion then the market is not that bad, I must admit I never vote. Majority of aim companies are not getting anywhere, most of the time we invested to pay the board salaries and hope they will doing something good...

You will never see me promote or suggest anyone to buy a share because I know too well the aim and morally I feel bad if it doesn't come good which is most of the time.

coffeecups, this is the nature aim market, I have been trading/investing for 10 years in this market and I have never seen one which doing well, the best ones I have ever seen would be holding same price value or slightly lower after many years and still trying. But I am pretty sure there are maybe some have been growing many folds but I guess you can count those companies on your fingers. So my lesson learnt from AIM after many years is that you must put put your stop loss and sell when you gain 10-30% profit, don't get too greedy. I am pretty sure if anyone follow that strategy then many of them are not in deep red anymore or actually doing well. The chance of XTR will come good is very thin, there will be excuses on the way...

Don't forget when Jan was CEO mr CB was the chairman, so don't blame everything on one man or pretend CB knew nothing or powerless, also they used to work together long time before XTR, they are the same group of dodgy people.

have any issue with XTR or Colin Bird then I suggest you should look for the posts from the joker JDAU and read, it will make you feel good straight away, that guy sees no negative in XTR at all, everything to him is rosy. I wonder how much salary or expenses Colin has been claiming from XTR each year, you can moan as much you like the guy is doing well, get pay regularly...

should not take too much comment from John g, he has been wrong all along for the last few years and if anyone has been following him then you should be in deep red by now. I have nothing against him but most of his comment was very much guessing and not realistic of what happening but he presented to the way he knows the company inside out. Years ago at one time I thought I crossed the 3% of owing Val shares but it is very minimal now.

As a business person I think you should not put too much hope into val401 deal because up to now we have very little result from the trials and the target has been shifted significantly. Before Val said val401 would kill late stage cancer and now it is used to improve quality of life before they die. If the deal is that great and it is not far anyway because the phase iii is next year then Val should wait and not to raise money for the development of 101 and 301 because financially this share is very much not much left.

About val201, even Val completed phase 2a successfully then still no guarantee it will be bought by another company or improve the sp. if you want to see evidence then just pop over to SCLP, they had great redults 2a with their sclb1 compound with many patients still alive after years but the sp is actually going down and no company buying.

I am the same like most of you, I wish the company do well and I am completely wrong because it is not just for us but for many sufferings which is more important than the money but personally after almost 8 years following this company I have feeling Val 201 and 401 won't go anywhere, the future maybe 101 or 301...

I know you have been here long time and you have always been positive about VAL but from my experience with this company I do not see any positive deal any time in near future. There will be JV for 401 to go to phase 3 but from the look of it it seems like the deal is very minimal and may not see any income at all...

I have such feeling VAL will be more vocal with 301 and 101 to justify their business as if 201 is any good then we should have some concrete positive news and results by now considering this is just only phase 2a and has been running for at least 5 years.

I still have shares in here but the value is peanut. I know some people would say you should not invest in a company at early stage but wait until near to result then join in like now, but there will be long shot for 101 and 301. Also there are other bio tech companies doing well even in early stage clinical trials like SAR, I don't invest in there but their management team seem to hold the company together quite well over the years.

Anyway, all the best and it is good to see you are still around.

countless of times over the last 7-8 years with this company. As I have said many times there is no deal any time soon in near future folks. There are 2 things that really upset me most are:
1) Val 201 has been in clinical trials phase 2a for the last 5 years and I just wonder how long it would take to complete 2b.
2) Now we are spending money on preclinical trials like 101 and 301, just imagine for those compounds into clinical stage like 201 would be at least another 5-7 years.

The bottom line is that Val seems to have many compounds but none could make any money at all or at least attract a partner to help out with the financial. I cannot help but keep thinking that they have come to come up with new compounds as an excuse to raise money to justify for their work and fund for their salaries

Great to hear from you again and I have nothing to criticise you but this is my feeling about you at the time, what you really should not do at the time was talking down MAGP after you sold your shares considering you were very up beat and positive about MAGP just few days before that. I think Baron was smart because he would not tell anyone when he sold the shares and I guess no one really know either, also as far as I know he never talk down the shares even after he sold. I often say if anyone wants to get tips from buy shares then follow Baron, you rarely see him ever spends time talk down a share, he always looks for the next potential to buy in. The guy is smart.

In my 8 years with AIM, I guess we all should have moral, you buy/sell the shares in your own time and quietly do it, I hate to know my action may influence others decisions especially if it turned out with negative outcome.

Firstly, VAl hasn't got a product yet, all they have is a bunch of compounds. Secondly, Satu has been talking about deal(s) for at least 6 years, this is not new. We are sitting here guessing and moaning about why VAl don't deal for VAL401, it could be no one has shown any interest yet or more data is needed or the right price is not met or the partnership offered was not attractive, it could be anything...the bottom line is that if the deal is imminent then I don't think Suzy would go into various conferences like the one in June to meet new potential partners. Still a long shot to go..

Uncanny, you are very much have no clue and the way you posted it tells me you are desperate for people to buy in. My post said VAL201 phase i/ii has been running for at least 4 years, just read carefully before reply.

Also it seems you have zero knowledge about the phases in clinical trials. I hope you do understand the differences in phase i/ii and phase ii. It cracked me up when you said val201 will be fast-tracked to phase iii or JV. Very amateur poster indeed.

Yes, VAL may need to partner to complete phase ii but this is future and no one know, for now forget phase iii, it is still a long shot to reach. Even there is a partner in there is no guarantee VAL would get a huge sum. Just pop over to SCLP and have a look, they completed SCIB1 phase i/ii long time ago and now trying to raise money for phase ii.

just ignore people on twitter or other platform, they have no clue and most likely guessing like people on this board. I said few weeks ago and it was unpleasant to read but the reality is that there won't be any deal in near future. People and Satu have been talking about deals in the making for at least 5-6 years now. I have so much experience with this share, it won't go anywhere for foreseeable future. Even if we completed val201 phase i/ii tomorrow there is no guarantee we would get a deal either, just look around at other companies who achieved this phase for their own compound(s) and see for yourself, but it is a milestone step as it has been going on for at least 4 years now,

Andrew4444, I rarely post on here but I occasionally read some posts, if I am not wrong then just 7-8 days ago you posted on here and said you would stop posting and may only visit this board once a month but it seemed you have forgotten what you posted. Anyway, I am not having a go at you just that be careful what you say, it is great to have someone like yourself to keep this board alive but at the same time you don't want to be like Jan or Colin who constantly give false hopes and broken promises. I said early summer last year that I did not trust Colin and in my eyes he was a con man like Jan until he could prove regular income.

Up to now he is the same like Jan, the worst thing is that since he took over he carried on raising money where Jan left off and the sp is actually a lot worse than from the day he took over, I cannot remember exactly but it was around 6-7p but I could be wrong. Keep going Andrew444, and btw, I have been in aim market for more than 8 years...

nomlungu, nowadays I don't check this board as often as I used to be as I know we will not going anywhere for many more months if not years. You raised a point that "...we are at critical point...", to be honest we have been at critical point for years, just that this company has many compounds but none could make a deal, we might hear more about 101 or 301 then these compounds will take at least another 5-6 years...don't forget 201 has been in clinical stage for at least a good 4-5 years, 401 is still a long time to go, they may release a positive news here and there but still long way to go. Take note of this, whenever you see a company gives presentation at any show it means that they need new investors, they need money and importantly in a short or medium term there would n't be anything happening. There are many posters on here talking about deal is happening and they have been saying that for years and obviously they have no clue apart from trying to get more people buy in. All the best.

It is not a pleasant situation to be in, I used to lose almost �50K on this share and stayed away for almost 3-4 years now but never expected it to come to this. At the end of day it is just money, your health and family are more important also very few people actually making money in AIM, most are in red (losing money) in different ways...All the best.

Forget the notion of selling Manica, people like CB needs these kind of companies running for them to earn their living, without Xtr then less income for him, he runs the company so he has various ways paying to himself without the need of taking salary.

gfb258, that person maybe know something or may as clueless as you and me because if you are here long enough then many years ago there was another private investor (Peter) who had way more than 3% and now if he is lucky he would own less than 0.4%. Also at one stage in the past I thought I crossed the 3% line but now I am 95% downed, the chance for me to recover is very little to none and I am still as clueless as 7 years ago apart from hope after hope...

Casper768, agreed about the 2p, but if you have been with VAL long enough then will notice that 2p is normal because majority of VAL placings they would give at least 30% discount, not sure why but it was like that for years and sometime more, it seems like they are desperate for funds.

Uncanny, most of you guys here are very much new kids on the block so I don't think you know much about the company and there is not much point for me to discuss because I am bored. Just look at SAR or SCLP, I don't invest in those companies but VAL was way way more advanced than SAR but SAR are still strong after 6-7 years but VAL has lost at least 95% since those years. Do you really think some big boy will take over or JV 401 any time soon?? or do you really believe val 201 will come good soon?

Uncanny, you are right it is 10% and for people like myself there is not much change either because I have been here more than 7 years then this is nothing because I am already around 95% down. This company spend so much money compare to others biotech companies and Satu has been talking about making deal since my early days which were at least 6 years ago.

I agreed with roses, most people invested or traded in AIM market are very much in red, very few people who actually make money in this market at all, most money go to the BODs and their employee or mms. It is better to invest in 100 or 200.